{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "decreases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uniprot:P61026",
      "entity_text" : "Rab10",
      "entity_type" : "protein"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "pubchem:8083",
      "entity_text" : "morpholine",
      "entity_type" : "simple_chemical"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "Consistently, pre-incubation with the potent LRRK2 inhibitor cis-2,6-dimethyl-4-(6-(5-(1-methylcyclopropoxy)-1H-indazol-3-yl) pyrimidin-4-yl) morpholine (MLi-2) [XREF_BIBR] blocked appearance of the retarded Rab10.",
  "reading_complete" : "2020-08-08T19:47:15Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-08T19:41:42Z",
  "trigger" : "blocked",
  "evidence" : [ "morpholine (MLi-2) [ XREF_BIBR ] blocked appearance of the retarded Rab10" ],
  "pmc_id" : "5095898",
  "score" : 0
}